Dr Kirit Ardeshna, Consultant Haematologist
Dr Kirit Ardeshna
Consultant Haematologist
Dr Kirit Ardeshna MD, MA (Cantab), FRCP (UK), FRCPath
Consultant Haematologist
Dr Kirit Ardeshna
Consultant Haematologist MD, MA (Cantab), FRCP (UK), FRCPath
Dr Ardeshna is a recommended Consultant Haematologist
Areas of expertise
- Blood diseases (clinical haematology)
- Lymphoma
- Chronic lymphocytic leukaemia
- Blood cancer
Recommendations for Dr Ardeshna
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byDr Anoushka Luthra, GP
❝Good bedside manner. Holistic approach.❞
byDr Alastair O'Brien, Gastroenterologist
❝I have shared a few patients with him and he seems to be a very accomplished Haematology Consultant.❞
by Dr Gavin Johnson, Gastroenterologist
❝Brilliant haematologist and excellent patient feedback❞
byDr Alastair O'Brien, Gastroenterologist
❝I have shared a few patients with him and he seems to be a very accomplished Haematology Consultant.❞
by Dr Gavin Johnson, Gastroenterologist
❝Brilliant haematologist and excellent patient feedback❞
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
About Dr Kirit Ardeshna
GMC number: 3483949
Year qualified: 1990
Place of primary qualification: University of Cambridge
Areas of expertise
- Haemato-Oncology
- Leukemia
- Lymphoma
- Myeloma
Professional memberships
Articles by Dr Kirit Ardeshna
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial
Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial
Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection
Update: the investigation and management of follicular lymphoma
